GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vicore Pharma Holding AB (OSTO:VICO) » Definitions » Beginning Cash Position

Vicore Pharma Holding AB (OSTO:VICO) Beginning Cash Position : kr1,156.00 Mil (As of Mar. 2025)


View and export this data going back to 2015. Start your Free Trial

What is Vicore Pharma Holding AB Beginning Cash Position?

Vicore Pharma Holding AB's Beginning Cash Position for the quarter that ended in Mar. 2025 was kr1,156.00 Mil.

Vicore Pharma Holding AB's quarterly Beginning Cash Position increased from Sep. 2024 (kr358.65 Mil) to Dec. 2024 (kr1,170.68 Mil) but then declined from Dec. 2024 (kr1,170.68 Mil) to Mar. 2025 (kr1,156.00 Mil).

Vicore Pharma Holding AB's annual Beginning Cash Position declined from Dec. 2022 (kr294.20 Mil) to Dec. 2023 (kr256.80 Mil) but then increased from Dec. 2023 (kr256.80 Mil) to Dec. 2024 (kr333.62 Mil).

Vicore Pharma Holding AB Beginning Cash Position Historical Data

The historical data trend for Vicore Pharma Holding AB's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vicore Pharma Holding AB Beginning Cash Position Chart

Vicore Pharma Holding AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 187.59 248.62 294.20 256.80 333.62

Vicore Pharma Holding AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 340.22 431.17 358.65 1,170.68 1,156.00

Vicore Pharma Holding AB Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Vicore Pharma Holding AB Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Vicore Pharma Holding AB's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Vicore Pharma Holding AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vicore Pharma Holding AB (OSTO:VICO) » Definitions » Beginning Cash Position
Comparable Companies
OSTO:HNSA OSTO:BINV OSTO:GENO OSTO:EGTX OSTO:XSPRAY OSTO:SANION OSTO:SYNACT OSTO:DMYD B XSAT:HAMLET B OSTO:IBT B VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
6Y4:Germany
Address
Kornhamnstorg 53, Stockholm, SWE, 111 27
Website
https://www.vicorepharma.com
Vicore Pharma Holding AB is a clinical-stage pharmaceutical company focused on severe lung diseases. The company is establishing a portfolio in respiratory diseases, including idiopathic pulmonary fibrosis (IPF). Its C21 is a small molecule angiotensin II type 2 receptor agonist (ATRAG) currently in phase 2b development for IPF. The company also has an investigational medical device in clinical development, namely, Almee, which is a digital therapeutic leveraging cognitive behavioral therapy created to address the psychological impact of living with pulmonary fibrosis.

Vicore Pharma Holding AB Headlines

No Headlines